Low ball offer3 Aug 2021 09:59
Any one thinking along these lines? I’ve not read this bb for a while but I see Guy and Jace are here all day, every day posting their frustrations and fears. Either you’re both invested way above your necks or you’ve an agenda. Easy for me personally to judge which side of the fence you’re on. Whether you’re positive or negative on this stock however, you have to admit the comms are utterly dreadful and DB has done a poor job in keeping sh informed.
I would say though that we have been told to expect a three month delay so won’t hear any news on FDA or EUA until Oct. Disappointing? Yes, for sure, but at least we know not to continually ask for news on that front until then, so why waste your breath? Lack of news on other fronts is equally frustrating, sales in particular but again, have we been told to expect anything right now?
The silence is odd so I’m still inclined to think a deal could have been lined up behind closed doors, dependent on FDA and EUA news, hence it’s perhaps all informal at this stage and no requirements to announce anything in an RNS - plus the likelihood of NDAs being signed between parties until things become more certain. All fanciful?? Or does anyone else here think DB could have lined this up and land himself a new position and to be rewarded handsomely (in terms of shares and options etc) by a potential purchaser?
I hope for one of two things. Either there is an update on sales very soon which is positive and gets the sp moving back towards £1 or that hypothetical low ball offer lands and amounts to £1 - £1.50 per share. I’ve loaded up whilst we’re sitting at such a low price and so am now quietly confident I can rescue this investment.
GLA